title: [The first case of single pancreas transplantation in Hungary].
abstract: Simultaneous pancreas kidney (SPK) transplantation is the only routinely used therapeutic option which can provide insulin independence, euglycemia and good renal replacement for type I diabetes mellitus patients with end stage renal disease. Several patients have some complications of diabetes without renal failure. For these patients pancreas transplantation alone is a therapeutic option. The first pancreas transplantation alone was performed 6 years after the launch of our pancreas transplant program. The patient was a 40-years-old man. Enteric drainage was used with portal venous drainage. Anti IL-2. R antibody, daclizumab was given as prolonged induction therapy. In spite of the technical and immunological difficulties there were neither technical failures nor acute rejection. 3 years after the transplantation the patient has a good quality of life without insulin therapy with excellent renal function.
  
  
  CONCLUSIONS
  PTA transplant is a routinely used therapeutic option with good survival rate and good quality of life for type I diabetes mellitus patients without end stage renal disease.
authors.affiliation: Pécsi Tudományegyetem, Orvostudományi és Egészségtudományi Koordinációs Központ, Altalános Orvostudományi Kar, Sebészeti Klinika, Pécs, Hungary. peter.szakaly@aok.pte.hu
authors.forename: Péter
authors.initials: P
authors.lastname: Szakály
authors.forename: Károly
authors.initials: K
authors.lastname: Kalmár Nagy
authors.forename: István
authors.initials: I
authors.lastname: Wittmann
mesh_terms: D000328:Adult; D004322:Drainage / Q000379:methods; D006291:Health Policy; D006801:Humans; D006814:Hungary; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D016035:Pancreas Transplantation / Q000191:economics / Q000276:immunology / Q000379:methods / Q000534:rehabilitation; D016559:Tacrolimus / Q000008:administration & dosage; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage; D014481:United States
chemical_list: D007166:Immunosuppressive Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D009173:Mycophenolic Acid; D016559:Tacrolimus; D008775:Methylprednisolone